Key references: Prevention of neonatal Streptococcus agalactiae (group B streptococcus) disease

Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2017: second Australian report on antimicrobial use and resistance in human health. Sydney: ACSQHC; 2017. https://www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/resources-page/
Hughes RG, Brocklehurst P, Steer PJ, Heath P, Stenson BM, on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease: Green-top Guideline No. 36. BJOG 2017;124(12):e280–e305. https://www.ncbi.nlm.nih.gov/pubmed/28901693
Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev 2014;(6):CD007467. https://www.ncbi.nlm.nih.gov/pubmed/24915629
Palasanthiran P, Starr M, Jones C, Giles M, editors. Management of perinatal infections. Sydney: Australasian Society for Infectious Diseases; 2014. http://www.asid.net.au/resources/clinical-guidelines
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), Women's Health CommitteeMaternal group B streptococcus in pregnancy: screening and management [C-Obs 19]. Melbourne: RANZCOG; 2003 [reviewed 2016]. https://www.ranzcog.edu.au/Statements-Guidelines
Verani JR, McGee L, Schrag SJ, National Center for Immunization Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59(RR-10):1–36. https://www.ncbi.nlm.nih.gov/pubmed/21088663
World Health Organization (WHO). WHO recommendations for prevention and treatment of maternal peripartum infections. Geneva: WHO;2015. https://www.who.int/publications/i/item/9789241549363